1[1]Ochsner M.Photodynamic therapy:the clinical perspective.Review on applications for control of diverse tumorous and non-tumorous diseases[J].Arzneimittelforschung,1997,47:1185～1194.
2[2]LatkowskiB.Use of sensitizers and photo laser for diagnosis and treatment of malignant tumors.Otolarynpol pol,1995,49[20]:205～208.
3[3]Fingar VH,Kik PK,Haydon PS,et al.Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative(BPD).Br-J-Cancer.1999 APR:79(11)1702.
4[4]Engbrecht BW,Wenon C,Kachur AV,et al.Photofrin-mediated photodynamic therapy induced vascular occlusion and apoptosis in a human sarcoma xenograft model.Cancer-Res.1999SEP 1;59(17):4334～4342.
5[5]Webber J,Herman m,Kessel D,et al.Photodynamic treatment of neoplastic lesions of the gastrointestinal tract.Langenbecks-Arch-Surg.2000JUL;385(4):299～304.
6[6]Oleinick NL,Evans HH.The photodynamic therapy:cellular targets and mechanisms[J].Radiat Res,1998,150(5):S146～156.
7[7]Chiu SM,Oleinick NL.Dissociation of mitochondyial depolarization from cytochrome c crelease during apoptosis induced by photodynamic therapy.Br-J-Cancer.2001Apr20;84(8):1099～1106.
8[8]Mori M,Kuroda T,Obana A,et al.In vitro plasma protein binding and cellular uptake of ATX-S10(Na),a hydrophilic chlorin photosensitizer.Jpn-J-Cancer-Res.2000 Aug;91(8):845～852.
9[9]Halkiotis K,Yova D,Pantelias G.In vitro evaluation of the genotoxic and clastogenic potential of photodynamic therapy.Mutagenesis.1999 Mar;14(2):193～198.
